APOA1 and cancer: Collectively, the aforementioned in vitro and animal studies provide convincing evidence that ApoA-I affects many of the originally proposed hallmarks of cancer [171], including sustained proliferative signaling, resistance to cell death, angiogenesis, and activation of invasion and metastasis (Figure 2).